Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 5% minoxidil and topical epinephrine for prevention of chemotherapy-induced hair loss in breast cancer
IRCT20200205046380N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in Chemotherapy-induced alopecia (CIA) comparing 5% minoxidil topical, topical epinephrine and placebo topical control (3 arms). Primary endpoint: prevention of chemotherapy-induced hair loss. Started Dec 2019; status: completed.
02
Drugs
minoxidilepinephrine
03
Conditions
Chemotherapy-induced alopecia (CIA)
Beyond the preview
Go deeper on IRCT20200205046380N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200205046380N1.